03Apr 2019

A NOVEL APPROACH IN PATIENT CARE AND NON-PHARMACOLOGICAL TREATMENT FOR RHEUMATOID ARTHRITIS.

  • Department of Pharmacy Practice, Srinivas College Of Pharmacy,Valachil, Manglore.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

RheumatoidArthritis (RA) is a chronic, systemic autoimmune disease characterized by persistent inflammation of synovial joints, often leading to joint destruction and disability. The major goals of treatment are to relieve pain, reduce inflammation, slow down or stop joint damage, prevent disability and preserve or improve the patients sense of wellbeing and ability to work.[1] RA, a chronic disease affecting 0.5%?1% of adults, is characterized by persistent syno?vitis, systemic inflammation, and immunological abnormalities.

  1. Shaw K, Zochling J, WinzenbergT.Nonpharmacological interventions for rheumatoid arthritis.Australian Family Physician. 2007 oct;36(10):840-1.
  2. Tanaka T, Hishitani Y, Ogata A.Monoclonal antibodies in rheumatoid arthritis: Comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors. Dove Press.2014 April;8(7);141-2.
  3. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023-2038.
  4. Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum. 2011;63(3):573-586.
  5. David S. Pisetsky.Advances in the treatment of Rheumatoid Arthritis.NCMJ.2017;78(5):337-9.
  6. Nam JL, Villeneuve E, Hensor EM, Conaghan PG, Keen HI, Buch MH, et al. Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study). Ann Rheum Dis. 2014;73(1):75-85.
  7. Jalal H, O?Dell JR, Bridges SL, Jr., Cofield S, Curtis JR, Mikuls TR, et al. Cost-effectiveness of triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis. Arthritis Care Res (Hoboken). 2016;68(12):1751-1757.
  8. Joshi M.Advances in the management of Rheumatoid Arthritis.J MGIMS.2012;17(2):6-12.
  9. Kalaivani M, Abhishank, V Kalaiselvan.Therapeutic monoclonal antibodies and need for targeted Phamacovigilance in India.mAbs.2015;7(1):276-80.
  10. Mahajan TD, MikulsTR.Recent advances in the treatment of Rheumatoid Arthritis.curropin Rheumatol.2018 May;30(3):231-37.
  11. Non-drug care for RA-is the era of evidence-based practice approaching?Rheumatology.2007 June;149(46):1397-1404.
  12. Caspersen CJ, Powell KE, Christenson GM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 1985;100:126?31.
  13. Vlieland VTPM. Rehabilitation of people with rheumatoid arthritis. ClinRheumatol (Best Pract Res Cl Rh) 2003;17:847?61.
  14. Oosterveld FGJ, Rasker JJ. Treating arthritis with locally applied heat or cold. Semin Arthritis Rheum 1994;24:1?10.
  15. Van Tubergen A, van der Linden S. A brief history of spa therapy. Ann Rheum Dis 2002;61:273?5.
  16. Heide A, Jacobs JWG, van Albada-Kuipers GA, Kraaimaat FW, Geenen R, Bijlsma JWJ. Self report functional disability scores and the use of devices: two distinct aspects of physical function in rheumatoid arthritis. Ann Rheum Dis 1993;52:497?502.
  17. Janisse DJ. Prescription footwear for arthritis of the foot and ankle. ClinOrthopRelat Res 1998;349:100?7.
  18. Cunningham RN, ZuckSK.Nonpharmacological treatment of pain in Rheumatic diseases and other Musculoskeletal pain conditions.curropin Rheumatol.2013 February;15(2):306.
  19. Schur PH, GibofskyA,James R O'Dell,RomainPl.nonpharmacologic therapies and preventive measures for patients with rheumatoid arthritis.uptodate;2018 July.
  20. Donzelli A, schivalocchi A. lifestyle and rheumatoid arthritis:prevention and non-pharmacological treatment.JVASC.2016;2(4):9544.100117.
  21. Carr AJ.A patient Centered Approach To Evaluation and Treatment in Rheumatoid Arthritis: The Development of a clinical tool to measure patient perceived handicap.British Journal of Rheumatology.1996;35:921-932.
  22. Stoffer MA, Smolen JS, Woolf A, Ambrzic A, Baswort A, Carmone L et al.Development of patient centred standards of patient centred standards of care for Rheumatoid Arthritis in Europe: the eumusc.netproject.Ann Rheum Dis.2013;20141(73):902-905.
  23. Catherine H, Maclean, Louie R, LeakeB.Quality of care for Patients with Rheumatoid Arthritis.American Medical Association.2018 dec;2000(284):984-921.
  24. Jacobi CE, Boshuizen HC, Rupp I, Huibert J DinantHeertruidis A M Van Den Bos.Quality of rheumatoid arthritis Care:The patient's perspective .International Journal for Quality in Healthcare.2014 Nov;16(1):73-81.
  25. Voshaar MJH, Nota I, Van De MAFJ.Patient centered care in established rheumatoid arthritis.doi.2015 sept:007.
  26. Stamm T, Stoffer M, wit M, Redlich K, Woolf A, SmolenJ.Putting patients first:the need for evidence based and patient centered standards of care in rheumatoid arthritis.Future Medicine.2014;9(1);1-2.
  27. Maria D, Acelajado MC, Luck J, Ta H,Chernoff D, Florentino J, Peabody JW.Variations and practice in the care of patients with rheumatoid arthritis:Quality and cost of care.JClin Rheumatol.2014 march;20(2);79-86.

[Athira. PV and Shabaraya AR. (2019); A NOVEL APPROACH IN PATIENT CARE AND NON-PHARMACOLOGICAL TREATMENT FOR RHEUMATOID ARTHRITIS. Int. J. of Adv. Res. 7 (Apr). 427-432] (ISSN 2320-5407). www.journalijar.com

Athira P Vijay
Doctor of Pharmacy( student)

DOI:

Article DOI: 10.21474/IJAR01/8835      
DOI URL: https://dx.doi.org/10.21474/IJAR01/8835

Download Full Paper

Download PDF No. of Downloads: 45 | No. of Views: 113